MedWellAI (MWAI) EBIAT (2016 - 2025)
MedWellAI (MWAI) has disclosed EBIAT for 12 consecutive years, with -$287519.0 as the latest value for Q4 2025.
- Quarterly EBIAT rose 60.6% to -$287519.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.0 million through Dec 2025, up 50.69% year-over-year, with the annual reading at -$2.9 million for FY2025, 74.4% up from the prior year.
- EBIAT for Q4 2025 was -$287519.0 at MedWellAI, up from -$653607.0 in the prior quarter.
- The five-year high for EBIAT was $1.3 million in Q3 2021, with the low at -$22.1 million in Q2 2023.
- Average EBIAT over 5 years is -$3.2 million, with a median of -$746628.5 recorded in 2022.
- Peak annual rise in EBIAT hit 446.59% in 2021, while the deepest fall reached 3630.14% in 2021.
- Over 5 years, EBIAT stood at -$515261.0 in 2021, then tumbled by 48.2% to -$763597.0 in 2022, then soared by 52.91% to -$359564.0 in 2023, then tumbled by 102.93% to -$729660.0 in 2024, then skyrocketed by 60.6% to -$287519.0 in 2025.
- According to Business Quant data, EBIAT over the past three periods came in at -$287519.0, -$653607.0, and -$471112.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.